Regulatory submission plan template for pharma and biotech

A submission plan is more than a list of documents and dates. It is the controlled model connecting the regulatory objective, evidence strategy, content structure, functional work, dependencies, reviews, decisions, technical publishing, and authority interaction. The plan should make it possible to explain not only when the submission is targeted, but why that date remains credible.

ICH organizes the Common Technical Document into five modules: region-specific information in Module 1 and common quality, safety, and efficacy information across Modules 2 through 5. FDA identifies eCTD as the standard electronic format for applicable CDER and CBER submissions. The working plan must respect that content structure while also managing the program work required to create, approve, and publish it.

1. Submission charter

Begin with a one-page charter that defines the planning basis:

• Product, indication, dosage form, route, and development stage.
• Authority, review center or division, submission type, pathway, and region.
• Target submission date and the business or development decision it supports.
• Scope boundaries: initial application, amendment, supplement, response, or another lifecycle activity.
• Known agency agreements, commitments, precedents, and unresolved questions.
• Core assumptions about data availability, manufacturing, studies, partners, vendors, and resources.
• Named plan owner, regulatory lead, functional leads, and executive decision owner.

2. Workstream structure

Use workstreams that reflect how the submission is actually produced. A typical plan may include:

3. Minimum task fields

Every task should be stable enough to survive export into another working view. Capture:

• Stable task identifier and workstream.
• Clear action-oriented task name and objective completion criterion.
• Accountable owner and supporting functions.
• Planned start, planned finish, duration, and confidence level.
• Predecessors, dependency type, lag, and any external dependency.
• Milestone or decision-gate status.
• Evidence or document produced.
• Source assumption, authority commitment, or gap that created the task.
• Current status, percent complete, forecast date, risk, and recovery action.

4. Plan evidence readiness separately from authoring

A document cannot be completed simply because its writing window has started. For each major content area, distinguish:

1. Evidence available: studies, analyses, manufacturing records, datasets, and decisions exist.
2. Evidence interpreted: the team has agreed on the meaning, limitations, and regulatory position.
3. Content authored: the document reflects the approved interpretation.
4. Cross-functional review complete: dependencies and inconsistencies are resolved.
5. Approval complete: required accountable personnel have approved the controlled version.
6. Publishing ready: technical, metadata, hyperlink, formatting, and placement requirements are satisfied.

Combining these into one “document complete” date conceals risk until late in the schedule.

5. Build dependencies before committing to dates

Validate the logic network before polishing the Gantt chart. Common dependencies include:

• Database lock before final analyses and clinical study report completion.
• Process or analytical readiness before final quality summaries.
• Integrated data interpretation before benefit-risk, labeling, and executive summaries.
• Gap closure or authority feedback before finalizing a proposed strategy.
• Approved source documents before publishing assembly and technical validation.
• Partner, vendor, master-file, translation, and facility information received on time.

Track external dependencies explicitly. A schedule is not credible when the most important dates are controlled by unnamed assumptions.

6. Include decision gates

Decision gates should state what must be known, who decides, and what happens next. Examples include:

• Pathway and submission-scope confirmation.
• Data-cut selection and analysis readiness.
• Manufacturing and stability position acceptance.
• Benefit-risk narrative approval.
• Labeling position approval.
• Submission-readiness decision and authorization to publish or transmit.

7. Model review cycles realistically

For major documents, include separate activities for authoring, functional review, comment resolution, quality control, approval, and publishing preparation. Define:

• Who reviews for scientific content, regulatory strategy, consistency, and document quality.
• How many review cycles are planned and what may trigger an additional cycle.
• Whether reviews run sequentially or in parallel.
• The cutoff for new data or scope changes.
• The escalation path when comments conflict or decisions remain unresolved.

8. Add publishing and submission-readiness controls

Technical publishing work should be planned early enough to influence source-document preparation. Include applicable activities for:

• Current eCTD standard, regional Module 1 requirements, and technical-conformance expectations.
• Document formatting, bookmarks, hyperlinks, granularity, metadata, and lifecycle operations.
• Dataset standards, validation, reviewer guides, and technical issue resolution.
• Submission assembly, quality control, validation, transmission readiness, and receipt monitoring.

Gulfstream Submission Planner coordinates the work; it does not replace an appropriately qualified eCTD publishing and transmission system.

9. Operate with a clear reporting rhythm

Use the same stable plan to produce different views:

• Working-team view: near-term tasks, dependencies, owners, and blockers.
• Functional-lead view: resource conflicts, evidence readiness, and review demand.
• Executive view: milestones, critical decisions, top risks, assumptions, and recovery options.
• Submission-readiness view: content, approval, publishing, and technical validation status.

10. Submission readiness questions

At each governance checkpoint, the team should be able to answer:

1. Which milestone is currently controlling the target date?
2. Which assumption has the highest chance of invalidating the plan?
3. Which content cannot finish because its evidence or decision is not ready?
4. Which external dependency lacks a committed delivery date?
5. Which cross-functional inconsistency could create rework?
6. What decision must be made next, by whom, and by what date?
7. If the target date moves, what was the first underlying dependency that changed?

A high-quality plan turns these questions into visible, controlled work—not a last-minute status exercise.